RSS

sickle cell disease

The US Food and Drug Administration (FDA) has approved Addmedica’s drug Siklos (hydroxyurea tablets) for the treatment of paediatric patients, two years of age and older, suffering from sickle cell anaemia. more

Technology

The US Food and Drug Administration (FDA) has approved Endari (L-glutamine oral powder), a treatment for patients aged five years and older with sickle cell disease, which reduces severe complications associated with the blood disorder. more

News

A new Managed Access Program (MAP) for the treatment of sickle cell disease has been announced for Emmaus Life Sciences’ pharmaceutical grade L-glutamine treatment (PGLG). more

News